Dr. James Dinulos achieves Advanced Mohs Surgery Board certification
PORTSMOUTH – Dr. James G. Dinulos is among the first in the United States to be certified by the American Board of Dermatology in the new subspecialty of Micrographic Surgery and Dermatological Oncology.
Dinulos is one of 1,677 active Mohs surgeons in the United States to pass the certification exam. Mohs surgery is a sophisticated technique used for the precision removal of cancerous skin cells while preserving healthy tissue. The new advanced sub-specialty ensures that the recipient is up-to-date with standards and adequately versed in specialized technique and pathology analysis.
Dinulos said, “Advances in medical science for the treatment of skin cancers are both exciting and promising … Mohs surgery is no exception. Being able to deliver the highest possible cure rate for most patients. skin cancers in a single outpatient visit is a real benefit for everyone in our community. “
Dinulos founded Seacoast Dermatology PLLC in 2014 and serves as the practice’s medical director and surgeon in Mohs. During his long career, Dinulos was Director of the Dartmouth-Hitchcock residency and dermatology program. He is currently Clinical Associate Professor of Dermatology at the Geisel School of Medicine in Dartmouth and Clinical Assistant Professor of Dermatology at the University of Connecticut.
Affiliated to several top-tier academic centers, Dinulos continuously shares his dermatology knowledge by holding numerous conferences in the United States and abroad. A respected clinical researcher, he writes and publishes internationally recognized medical reference books including Habif’s Clinical Dermatology, 7e, Dermatology DDx Deck, 2e, and Skin Disease, 3e. He is a member of the American Academy of Dermatology, the American Society for Dermatologic Surgery and the American Society for Mohs Surgery.
Contact Seacoast Dermatology at 603-431-5205 or visit SeacoastDermNH.com for more information on Dr. Dinulos.
The Wentworth-Douglass Diabetes Program achieves full CDC accreditation
DOVER – Wentworth-Douglass Hospital’s “Type 2 Prevention Program,” which targets people most at risk of developing type 2 diabetes, has received full accreditation from the Center for Disease Control and Prevention.
The Prevent Type 2 Program is a 12-month lifestyle change program launched by Wentworth-Douglass in 2018 as part of the CDC’s National Diabetes Prevention Program. Wentworth-Douglass offers the program as a free community health benefit aimed at people with prediabetes.
“It’s really about raising awareness in our community that prediabetes is real,” said Christine Wyrsch, manager of the Wentworth-Douglass Patient and Family Learning Center, which runs the program. “We want to catch those patients before they have diabetes.”
Program participants are sometimes referred by their doctors or accepted after taking a short quiz from the National Diabetes Prevention Program that determines an individual’s risk for type 2 diabetes.
The program is taught by CDC-certified hospital lifestyle coaches, diabetes educators, and dieticians. Through multiple courses, instructors work with participants to develop better lifestyle habits and achieve body weight and activity goals.
According to the CDC, one in three Americans has prediabetes, but those who participate in CDC lifestyle programs and lose 5-7% of their body weight and add 150 minutes of exercise per week can reduce their risk of developing type 2 diabetes up to 58% (71% for people over 60).
Wentworth-Douglass worked on multiple levels of accreditation with the CDC before gaining full accreditation. According to Wyrsch, full accreditation by the CDC will allow the hospital’s program more growth opportunities in the future.
“It really shows the people who come into the program that we’ve done all the work,” Wyrsch said. “We are crossing our t’s by punctuating our i’s, our coaches are fully trained and we are doing everything right that the CDC wants us to do.”
Wyrsch gave credit to coaches, educators and dieticians who worked tirelessly for three years to help the hospital meet CDC standards for full accreditation.
“It has been a great collaboration and I think what sets us apart from other programs in the area is that we are a hospital program run by content experts,” said Wyrsch.
Those interested in learning more about the Prevent Type 2 program can visit www.wdhospital.org/wdh/staying-well or contact the Wentworth-Douglass Patient & Family Learning Center at 603-609-6027 or [email protected] .
Children’s pediatrician Dartmouth Health selected for the 2022 Van Scoyoc Award
CONCORD – Charles Cappetta, MD, FAAP, pediatrician at Dartmouth Health Children and advocate for children’s health, has been selected as a recipient of the 2022 Sandi Van Scoyoc Legacy Award by the New Hampshire Children’s Health Foundation. The foundation is a major contributor to improving the health and well-being of children in the state.
Cappetta, or simply “Dr. Chuck ”to the countless patients and families, schoolchildren and others who were lucky enough to meet him, has been practicing pediatric and family medicine in Nashua, NH for over 30 years. Cappetta was awarded in a ceremony at the Dartmouth Health Regional Administrative Office in Bedford on Monday 6 June, where Gail Garceau, president of the New Hampshire Children’s Health Foundation, presented him with the award and a check for $ 2,500, which he donated to the Court Appointed Special New Hampshire Child Lawyers.
Cappetta completed his pediatric residency at Dartmouth Hitchcock Medical Center in Lebanon in 1993 and joined the pediatric practice at Hitchcock Clinic in Nashua, now Dartmouth Hitchcock Clinics Nashua, in 1993, where his practice has since flourished. . He will celebrate his 33rd anniversary with Dartmouth Health on June 26th.
“From the beginning of his career, Dr. Chuck’s practice has been guided by his belief that every child is unique and special. His passion for helping children grow has helped countless children become well-rounded, healthy and caring adults, “said Keith Loud, MD, chief physician of Dartmouth Health Children’s, chair of the department of pediatrics and vice president of the board. of the New Hampshire Children’s Health Foundation. “I was thrilled when my colleagues at the New Hampshire Children’s Health Foundation informed me that they voted for Dr. Chuck to be the recipient of this year’s Sandy Van Scoyoc Legacy Award.”
“While he has received many, many awards throughout his career, Dr. Chuck’s greatest achievement is the profound positive impact he has had on thousands of children and families across New Hampshire,” said Garceau. “It is with great appreciation and respect that the New Hampshire Children’s Health Foundation honors Dr. Chuck Cappetta with the Van Scoyoc Award for his tireless and far-reaching work with children and families,” she added.
The awards ceremony, held at the Dartmouth Health offices in Bedford, was attended by some colleagues from Cappetta Dartmouth Health and his children, Andrew, Kate, Kelsey and Alyssa, who surprised their father by virtually joining.
DHMC awarded Comprehensive Stroke Center certification
LEBANON, – Dartmouth Hitchcock Medical Center, a member of Dartmouth Health, has been awarded the Joint Commission Gold Seal and the American Stroke Association Heart-Check Mark for Comprehensive Stroke Center certification.
DHMC underwent a rigorous on-site review on March 15th and March 16th. During the visit, a team of reviewers from the Mixed Commission assessed compliance with relevant certification standards, including all that is required for the care of patients with ischemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage. This was done in coordination with regional emergency medical services, special interventions, advanced imaging, and neurocritical care. Mixed Commission standards are developed in consultation with health care experts and providers, measurement experts and patients. The reviewers also conducted on-site observations and interviews.
“This has been a rigorous inspection of all aspects of our program from top to bottom, and passing it is a testament to our dedication to providing excellent and comprehensive care,” added Timothy G. Lukovits, MD, medical director of the Department of Cerebrovascular Diseases and Stroke Program at DHMC.
The Joint Commission venture is a global engine of improving quality and patient safety in health care, helping organizations across the care continuum lead the way to zero harm.
Through comprehensive data management, performance improvement initiatives and training throughout our system, DHMC was able to meet the national performance measures required by the Joint Commission to deliver the best possible outcomes for our patients. For more information, visit www.jointcommission.org.